Carbonilla, Niel Zyca E.
HRN: 19-65-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
CEFTRIAXONE 1G (VIAL)
04/24/2023
05/01/2023
IV
750mg
Q12
PCAP
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes